US Patent Issued to APRINOIA THERAPEUTICS on Aug. 5 for "Compounds for degrading alpha-synuclein aggregates and uses thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,152, issued on Aug. 5, was assigned to APRINOIA THERAPEUTICS Ltd. (Wanchai, China).

"Compounds for degrading alpha-synuclein aggregates and uses thereof" was invented by Ming-Kuei Jang (Taipei, Taiwan), Paul Tempest (Taipei, Taiwan) and Yih-Shyan Lin (Kaohsiung, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds, compositions and methods useful for the treatment of neurodegenerative diseases, in particular synucleinopathies."

The patent was filed on March 4, 2022, under Application No. 17/687,550.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/...